Connected Drug-Devices: Ensuring Device Longevity and Success

Adding connectivity and smart functionality to drug-delivery devices will inevitably have an impact on the use process for the patient (whether this is the intention or not), and there are very specific patient-device dynamics that need to be considered to ensure that the implementation of this technology is successful across all patient populations. It may be time that we reconsider our traditional risk-based human factors approach and update it for this changing technology landscape by taking a more holistic approach to usability. The Challenge It has been suggested that some of the key driving forces for developing connected devices are tracking patient adherence, a move towards evidence-based treatment methods, and beating competitors to market.1 As a result of this, it is possible that user needs are not always being given the attention they deserve. Furthermore, while the barriers to the adoption of consumer technology are well known, these barriers are slightly different within the domain of medical technology, and may be particularly complex when the wide variety of patient demographics and specific disease and treatment types are added. Consequently, it is possible that user needs are also not understood as fully as they could be. Don't miss the MD&M West conference and expo, February 6–8, 2018. Use promo code "MDDI" for free expo admission and 20% off conference registration. Recent research has gone tried to improve our understanding of the potential barrie...
Source: MDDI - Category: Medical Devices Authors: Tags: Design Digital Health Source Type: news